ArticleHepatology (Baltimore, Md.)2026
Non-transcriptional activity of IRF3 promotes liver fibrosis and stress granule assembly via a dsRNA-TLR3-dependent pathway in hepatic stellate cells.
Article in Hepatology (Baltimore, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
BACKGROUND AND
aimsInterferon regulator factor 3 (IRF3) executes multiple transcriptional and non-transcriptional functions that regulate the development of metabolic liver diseases. However, the contribution of the transcriptional and non-transcriptional activities of IRF3 to hepatic fibrosis is unknown. APPROACH AND
resultsChronic carbon tetrachloride (CCl 4 ) and choline-deficient L-amino acid-defined-diets both induced fibrosis in C57BL/6J (wild-type) and mice expressing only non-transcriptional IRF3 activity ( Irf3S1/S1 ) but not Irf3 -deficient ( Irf3-/- ) mice. HSC-specific deletion of Irf3 ( Lrat-Irf3 ) also attenuated CCl 4 -induced fibrosis. Molecular pathways associated with the regulation of extracellular matrix were upregulated during differentiation in primary HSCs from wild-type and Irf3S1/S1 , but not Irf3-/- , mice. Fibrogenic gene expression was also reduced in primary HSCs from Irf3-/- , but not Irf3S1/S1 , mice upon TGFβ stimulation. IRF3 gene silencing in LX2 cells suppressed TGFβ-induced fibrogenic gene expression and collagen production. Proteomic analysis identified stress granule (SG) associated proteins within the IRF3 interactome, and IRF3 localized to SGs in LX2 cells upon stimulation with poly(I:C) or TGFβ. Mechanistically, differentiation of primary HSCs or stimulation of LX2 cells with TGFβ induced accumulation of endogenous double-stranded RNA (dsRNA), which triggered assembly of IRF3-containing SGs in a TLR3-dependent mechanism. TGFβ stimulated SG assembly in primary HSCs from wild-type and Irf3S1/S1 , but not Irf3-/- , mice, and SGs were detected in fibrotic human livers.
conclusionThe non-transcriptional activity of IRF3 is a key driver of hepatic fibrogenesis. Non-transcriptional activity of IRF3 is activated by the accumulation of endogenous dsRNA and TLR3-dependent assembly of IRF3-containing SGs and acts as a central regulator of HSC activation and hepatic fibrogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.